Published in Curr Opin Chem Biol on October 01, 2003
The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol (2009) 6.15
Fluorescence lifetime measurements and biological imaging. Chem Rev (2010) 3.99
Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol (2006) 3.98
Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging (2010) 3.88
Bright ideas for chemical biology. ACS Chem Biol (2008) 3.84
New technologies for human cancer imaging. J Clin Oncol (2008) 3.46
Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev (2008) 3.18
Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol (2013) 3.01
Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol (2010) 2.85
Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg (2005) 2.52
Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc Natl Acad Sci U S A (2007) 2.49
Bioimaging: second window for in vivo imaging. Nat Nanotechnol (2009) 2.48
Targeted zwitterionic near-infrared fluorophores for improved optical imaging. Nat Biotechnol (2013) 2.44
Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett (2009) 2.37
In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano (2010) 2.30
Synthesis and in vivo fate of zwitterionic near-infrared fluorophores. Angew Chem Int Ed Engl (2011) 2.19
A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging (2012) 2.18
Fluorescent analogs of biomolecular building blocks: design, properties, and applications. Chem Rev (2010) 2.16
High-power, computer-controlled, light-emitting diode-based light sources for fluorescence imaging and image-guided surgery. Mol Imaging (2009) 2.15
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med (2012) 2.13
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res (2008) 1.96
Multimodal MRI contrast agents. J Biol Inorg Chem (2007) 1.86
Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imaging (2010) 1.75
Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat Med (2012) 1.74
Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl (2008) 1.71
Tissue-like phantoms for near-infrared fluorescence imaging system assessment and the training of surgeons. J Biomed Opt (2006) 1.65
Peptides and peptide hormones for molecular imaging and disease diagnosis. Chem Rev (2010) 1.63
Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res (2011) 1.62
Real-time intraoperative assessment of the extrahepatic bile ducts in rats and pigs using invisible near-infrared fluorescent light. Surgery (2008) 1.60
Role of voltage-gated potassium channels in cancer. J Membr Biol (2005) 1.60
Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence. J Urol (2007) 1.57
PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano (2010) 1.52
Structured illumination enhances resolution and contrast in thick tissue fluorescence imaging. J Biomed Opt (2010) 1.49
Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur J Nucl Med Mol Imaging (2012) 1.49
Single-walled carbon nanotubes as a multimodal-thermoacoustic and photoacoustic-contrast agent. J Biomed Opt (2009) 1.48
Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proc Natl Acad Sci U S A (2011) 1.48
Cell tracking with optical imaging. Eur Radiol (2008) 1.47
Intraoperative near-infrared fluorescence imaging in perforator flap reconstruction: current research and early clinical experience. J Reconstr Microsurg (2009) 1.46
Real-time intra-operative near-infrared fluorescence identification of the extrahepatic bile ducts using clinically available contrast agents. Surgery (2010) 1.45
Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol (2006) 1.45
Near IR heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res (2010) 1.44
Peptide-based probes for targeted molecular imaging. Biochemistry (2010) 1.43
Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res (2010) 1.43
Self-luminescing BRET-FRET near-infrared dots for in vivo lymph-node mapping and tumour imaging. Nat Commun (2012) 1.42
Structure-guided engineering enhances a phytochrome-based infrared fluorescent protein. J Biol Chem (2011) 1.40
Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe. J Am Chem Soc (2008) 1.38
Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano (2013) 1.36
Optical imaging of mammary and prostate tumors in living animals using a synthetic near infrared zinc(II)-dipicolylamine probe for anionic cell surfaces. J Am Chem Soc (2010) 1.34
An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem (2009) 1.34
Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Breast Cancer Res Treat (2013) 1.33
Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano Carriers. Chem Mater (2012) 1.32
Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem (2008) 1.31
Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res Lett (2007) 1.30
Real-time, near-infrared, fluorescence-guided identification of the ureters using methylene blue. Surgery (2010) 1.29
Real-time assessment of cardiac perfusion, coronary angiography, and acute intravascular thrombi using dual-channel near-infrared fluorescence imaging. J Thorac Cardiovasc Surg (2009) 1.29
Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med (2010) 1.28
Localization and quantification of platelet-rich thrombi in large blood vessels with near-infrared fluorescence imaging. Circulation (2006) 1.28
Labeling of mesenchymal stem cells by bioconjugated quantum dots. Nano Lett (2007) 1.28
Seeing stem cells at work in vivo. Stem Cell Rev (2014) 1.28
Photostimulated near-infrared persistent luminescence as a new optical read-out from Cr³⁺-doped LiGa₅O₈. Sci Rep (2013) 1.26
Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol (2012) 1.26
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomedicine (2009) 1.25
Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light. Ann Surg Oncol (2010) 1.24
Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging. Cancers (Basel) (2010) 1.24
Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconjug Chem (2009) 1.23
Methods for lymphatic vessel culture and gene transfection. Microcirculation (2009) 1.23
Near-infrared fluorescent dye-doped semiconducting polymer dots. ACS Nano (2011) 1.23
Optimization of near-infrared fluorescent sentinel lymph node mapping in cervical cancer patients. Int J Gynecol Cancer (2011) 1.22
Determination of optimal rhodamine fluorophore for in vivo optical imaging. Bioconjug Chem (2008) 1.18
Imaging workflow and calibration for CT-guided time-domain fluorescence tomography. Biomed Opt Express (2011) 1.16
Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. EJNMMI Res (2011) 1.16
Multimodality molecular imaging of CD105 (Endoglin) expression. Int J Clin Exp Med (2010) 1.16
Intraoperative localization of insulinoma and normal pancreas using invisible near-infrared fluorescent light. Ann Surg Oncol (2009) 1.16
Design considerations for targeted optical contrast agents. Quant Imaging Med Surg (2012) 1.15
Rare-earth-doped biological composites as in vivo shortwave infrared reporters. Nat Commun (2013) 1.15
Molecular imaging perspectives. J R Soc Interface (2005) 1.14
In vivo fluorescence imaging in the second near-infrared window with long circulating carbon nanotubes capable of ultrahigh tumor uptake. J Am Chem Soc (2012) 1.14
Near-infrared fluorescence imaging of thoracic duct anatomy and function in open surgery and video-assisted thoracic surgery. J Thorac Cardiovasc Surg (2011) 1.14
Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg (2013) 1.14
Through-skull fluorescence imaging of the brain in a new near-infrared window. Nat Photonics (2014) 1.14
Remote activation of biomolecules in deep tissues using near-infrared-to-UV upconversion nanotransducers. Proc Natl Acad Sci U S A (2012) 1.13
Clinical potential of quantum dots. J Biomed Biotechnol (2007) 1.12
Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light. Semin Thorac Cardiovasc Surg (2009) 1.12
Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. ACS Nano (2013) 1.12
Multivalent scaffolds for affinity maturation of small molecule cell surface binders and their application to prostate tumor targeting. J Med Chem (2009) 1.10
Dual-mode laparoscopic fluorescence image-guided surgery using a single camera. Biomed Opt Express (2012) 1.10
Indocyanine green and lymphatic imaging: current problems. Lymphat Res Biol (2010) 1.09
Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence. Eur J Nucl Med Mol Imaging (2013) 1.09
Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol (2011) 1.09
Temperature-modulated fluorescence tomography based on both concentration and lifetime contrast. J Biomed Opt (2012) 1.08
A photo-multiplier tube-based hybrid MRI and frequency domain fluorescence tomography system for small animal imaging. Phys Med Biol (2011) 1.08
Accurate analysis of tumor margins using a fluorescent pH Low Insertion Peptide (pHLIP). Int J Mol Sci (2009) 1.07
Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging. J Am Chem Soc (2014) 1.06
NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. J Fluor Chem (2012) 1.05
Drug delivery monitoring by photoacoustic tomography with an ICG encapsulated double emulsion. Opt Express (2011) 1.04
Multiplexed Five-Color Molecular Imaging of Cancer Cells and Tumor Tissues with Carbon Nanotube Raman Tags in the Near-Infrared. Nano Res (2010) 1.04
Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes. J Urol (2012) 1.03
A near-IR uncaging strategy based on cyanine photochemistry. J Am Chem Soc (2014) 1.03
Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice. BMC Cancer (2008) 1.03